Airtable

56.15

-0.12

Anduril

53.97

-0.35

Anthropic

65.88

-0.14

Apptronik

17.05

-0.01

Canva

1,125.67

-2.38

Cerebras

33.43

+1.56

Cohere

163.47

-0.35

Cohesity

16.81

-0.04

Cursor (Anysphere)

228.31

-0.48

Databricks

108.02

-0.23

Discord

241.35

-0.51

Epic Games

451.15

-0.99

EquipmentShare

10.69

+0.06

Figma

34.10

-0.07

Figure AI

194.09

+0.93

Firefly Aerospace

5.93

-0.04

Flock Safety

16.13

+0.01

Gecko Robotics

48.33

+0.21

Glean

50.06

-0.11

Groq

25.21

+0.25

Tenpoint Therapeutics Stock

Last updated on June 19, 2025

Overview Market Valuation Revenue Funding Investors

How to buy Tenpoint Therapeutics

The world's most experienced Tenpoint Therapeutics brokers are here to advise you on buying and selling opportunities.

About Tenpoint Therapeutics Limited

Tenpoint Therapeutics is a biotechnology company focused on developing breakthrough bioscience technologies. Founded in 2020, the company specializes in conducting experimental development in natural sciences and engineering to unlock revolutionary new possibilities. With a team of experienced scientists and innovators, Tenpoint Therapeutics is dedicated to advancing research and pushing the boundaries of what is possible.

Founded

2020

Employees

Website

tenpointtherapeutics.com

Last round

Market Cap

Premium

Total Funding

Days Since Funding

707²

Coverage Ratio

Tenpoint Therapeutics Market

Transferability unknown

We do not know if Tenpoint Therapeutics allows direct stock transfers. if you know the current transfer rules for Tenpoint Therapeutics.

Tenpoint Therapeutics has low market activity. There are no buyers or sellers of Tenpoint Therapeutics at this time. It can take time for markets to develop around private companies. Buyer demand typically drives markets in private companies. Here are the major factors:

News: Positive company developments that garner extensive news coverage including large funding rounds or product launches can generate investor demand.
Size: Investor demand also tends to be correlated with company valuation where the larger companies attract more secondary market investor attention.
Sector: Hot sectors like AI can create halo effects that drive investor demand more broadly into the sector as a whole.
Age: Finally, older companies typically have more sellers as employees have vested and investors are pushed to liquidate positions to generate returns.

So, older large companies with continuous positive news cycles in hot sectors tend to be the most liquid. SpaceX is a good example of a highly liquid name.

or sign up and post an indication of interest to explore opportunities to transact Tenpoint Therapeutics.

Tenpoint Therapeutics Stock Price

Quarterly performance

Tenpoint Therapeutics stock is not currently traded in the private markets. We do not have enough data to print a price history for Tenpoint Therapeutics right now. If you can share any Tenpoint Therapeutics stock trade data or funding round price per share, then we can start pricing coverage for Tenpoint Therapeutics.

Tenpoint Therapeutics Valuation

We are missing all Tenpoint Therapeutics funding round valuations. Sometimes these details are not shared in funding announcements or corporate filings. If you can share valuations for any funding rounds that Tenpoint Therapeutics has done, then we can start valuation coverage for Tenpoint Therapeutics.

Frequently Asked Questions

Does Tenpoint Therapeutics have stock?

Yes. Tenpoint Therapeutics is a private venture-backed company. Investors usually purchase preferred stock and employees typically receive common stock options or restricted stock units (RSUs) as part of their compensation.

What is Tenpoint Therapeutics's stock symbol?

Since it is not publicly listed, there is no Tenpoint Therapeutics stock symbol or Tenpoint Therapeutics ticker symbol assigned for Tenpoint Therapeutics.

Private companies typically reserve a stock symbol up to two years prior to an IPO, and disclose this when they file a Form S-1 with the Securities and Exchange Commission when they start the IPO process.

How can I sell Tenpoint Therapeutics stock?

If you own shares of a private company, it may be possible to find liquidity for your holdings before the company goes public. Finding the right private market broker can make all the difference as the best brokers can leverage deep industry relationships and negotiate on your behalf.

If you are interested in selling private stock you can reach out to Premier brokers for more information.

How do Tenpoint Therapeutics pre-IPO trades work?

Private market transactions can be complex and may involve company approvals, legal purchase agreements and wires to third parties. Trades can take 30 - 60 days to complete which is why many investors work with experienced private market brokers to help guide the process.

Direct share transfers typically require issuer approvals. Issuers may exercise the right of first refusal (ROFR) in order to direct the seller to a buyer of their choosing.

Some issuers do not allow transactions. In these cases, buyers will need to purchase indirect interests in the business via special purpose vehicles (SPVs) or forward purchase contracts (forwards).

Is Tenpoint Therapeutics publicly traded?

Tenpoint Therapeutics stock does not trade publicly on Nasdaq or NYSE because it is still a private company. Tenpoint Therapeutics stock might be available for purchase in the secondary markets, but Tenpoint Therapeutics stock is not available for purchase by the general public, and can not be purchased through traditional brokerage accounts.

How can I buy Tenpoint Therapeutics stock?

Only accredited investors and qualified purchasers can buy private stock. These investors buy pre-IPO stock in the secondary market from existing employees and investors.

To learn more about the market for Tenpoint Therapeutics stock, talk to the best brokers on the planet.

How to invest in Tenpoint Therapeutics?

Accredited investors can purchase shares in private companies like Tenpoint Therapeutics. Investors can rely on Notice Premier Brokers to find supply and guide them through the trading process.

Because Tenpoint Therapeutics is privately held, its stock is not available for purchase through public stock exchanges like the NYSE or Nasdaq. Retail investors can not access this stock via traditional brokerage accounts, and are not allowed to invest directly in Tenpoint Therapeutics pre-IPO.

Popular companies

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON NOTICE.CO ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT. NOTICE, INC., TOGETHER WITH ITS AFFILIATES ("NOTICE") IS NOT A BROKER-DEALER, INVESTMENT ADVISER OR ANY OTHER TYPE OF FINANCIAL PROFESSIONAL. NO PLATFORM CONTENT SHOULD BE CONSIDERED AN OFFER, SOLICITATION OF AN OFFER, OR ADVICE TO BUY OR SELL SECURITIES OR ANY OTHER TYPE OF INVESTMENT OR FINANCIAL PRODUCT. BY USING THE PLATFORM YOU UNDERSTAND AND AGREE THAT NOTICE DOES NOT PROVIDE INVESTMENT ADVICE; RECOMMEND ANY SECURITY, TRANSACTION OR ORDER; FACILITATE BROKERAGE REFERRALS; OR PROVIDE ANY OTHER TYPE OF FINANCIAL PRODUCT OR SERVICE. YOU MAY NOT DIRECTLY PURCHASE SHARES OF PRIVATE COMPANIES ON THE PLATFORM. PRIVATE OFFERINGS AVAILABLE THROUGH THE PLATFORM INVOLVE THE OFFER AND SALE OF MEMBERSHIP INTERESTS IN LIMITED LIABILITY COMPANIES THAT MAY HOLD SHARES OF PRIVATE COMPANIES. ANY REFERENCES ON THE PLATFORM TO 'SHARES', 'PRICE PER SHARE', 'STOCK' OR OTHER SIMILAR TERMINOLOGY ARE FOR ADMINISTRATIVE CONVENIENCE ONLY. The content on the Notice website ("Platform") produced by Notice, in part, (the "Platform Content"), is based on aggregated data from the voluntary disclosure by certain of Notice's Users and/or publicly available information. Notice does not have an obligation to update Platform Content and none of the information provided by Notice constitutes investment, tax, or legal advice. All information provided by Notice is for informational purposes only. Platform Content is not an endorsement of and does not suggest any affiliation to any third parties related to the Platform Content. Notice makes no representations or warranties with respect to the Platform Content and will not be liable for Platform Content or any action (or inaction) taken in reliance on such Platform Content. Notice does not guarantee or makes any warranty of any kind, express or implied, regarding the timeliness, sequence, accuracy, or completeness of any Platform Content. All pricing information provided on the Platform is based on a number of factors, may not be accurate, and is not intended to reflect an active market, or the ability for any individual to transact at such prices. Notice does not independently verify any pricing information and assumes no responsibility for its accuracy. Pricing information displayed does not represent a quote or any other offer to buy or sell at any given price or quantity.